CHESTER, NY / ACCESSWIRE / January 20, 2015 / Repro-Med Systems, Inc. dba RMS Medical Products (OTCQB:REPR) today announced the appointment of Karen Fisher who will serve as Chief Financial Officer of RMS effective January 28th, 2015.
Ms. Fisher brings more than 18 years of financial experience in a variety of industries, most recently serving as Assistant Controller, Senior Manager for Armored Autogroup, Inc., a worldwide consumer products company, since February 2012. Before joining Armored Autogroup, Inc., she spent seven years at Gilman Ciocia, Inc., where she served in a variety of financial roles, including Chief Accounting Officer and Treasurer, and, earlier, as Controller. Before Gilman Ciocia, Inc., she held multiple financial management roles at The New York Times Company and Thomson Financial. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in accounting.
Andrew Sealfon, President of RMS, commented, "We're strengthening our team to execute on our long term sales growth and product line expansion strategy. Karen’s extensive experience and financial acumen will be invaluable as she joins our family during such an exciting time. Under Karen's leadership we will continue our focus on profitable growth and sound capital allocation for the benefit of all shareholders."
Ms. Fisher said, "Andrew and his team have led RMS to a time of great opportunity. The company has a strong balance sheet and an exciting portfolio of innovative products and application areas. I look forward to being part of the senior leadership team that is positioning RMS for growth and long-term success."
Barry Short, serving as Interim Chief Financial Officer since June 9th 2014, will remain with RMS as Director of Administration.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects","intends"," "anticipates", "will", or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's reports and registration statements filed with the Securities and Exchange Commission.
For more information please call:
Mike King
702-650-3000
Princeton Research
SOURCE: RMS Medical Products